The effectiveness of small heterodimer partner and FGF 19 levels in prediction of perinatal morbidity in intrahepatic cholestasis of pregnancy
- 14 February 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (5) , 1174-1178
Abstract
Fibroblast growth factor 19 (FGF19) and small heterodimer partner (SHP) are molecules responsible for controlling serum bile acid levels. We designed this study for evaluating the effects of FGF 19 and SHP in intrahepatic cholestasis of pregnancy (ICP). Fifty-six pregnant women having ICP and 20 healthy pregnant women were included in the study. The patients were followed up until delivery in terms of pregnancy-related morbidity/mortality. Serum FGF 19 and SHP levels were determined by enzyme-linked immunosorbent assay (ELISA). Serum FGF 19 and SHP levels were significantly higher in the patient group compared to the control group (p: .04, p: .003, respectively). In ROC analysis, SHP level above 1995 ng/L was found effective in predicting the need for neonatal intensive care unit (ICU) follow-up with 53.8% sensitivity and 77.8% specificity. High SHP levels were correlated with perinatal morbidity, mortality and neonatal ICU hospitalisation.Keywords
Funding Information
- Akdamar Fellowship Program, Department of Gastroenterology and Hepatology, Tulane University Health Sciences Center
This publication has 26 references indexed in Scilit:
- Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the diseaseScientific Reports, 2015
- Bile Acids as Hormones: The FXR-FGF15/19 PathwayDigestive Diseases, 2015
- Bile acid signaling and biliary functionsActa Pharmaceutica Sinica B, 2015
- Visual Analogue Scale: Evaluation of the Instrument for the Assessment of PruritusActa Dermato-Venereologica, 2012
- Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidAlimentary Pharmacology & Therapeutics, 2010
- The Role of Inflammation in Cholestasis: Clinical and Basic AspectsSeminars in Liver Disease, 2010
- Endocrine FGFs and Klothos: emerging conceptsTrends in Endocrinology & Metabolism, 2008
- Liver-specific Activities of FGF19 Require Klotho betaJournal of Biological Chemistry, 2007
- Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlothoJournal of Clinical Investigation, 2005
- Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication ratesHepatology, 2004